TAP
58
-3
GRMN
64
-4
WAT
59
-2
ALLE
35
-2
HES
58
-3
MTCH
37
-3
VRTX
54
-2
URI
43
-2
NVDA
52
-2
MSI
50
-8
MET
58
2
NEM
48
-2
PEP
45
4
KR
63
6
RL
72
-3
MAC
65
-2
FLR
48
-4
KHC
20
3
EXR
51
-2
K
53
2
TAP
58
-3
GRMN
64
-4
WAT
59
-2
ALLE
35
-2
HES
58
-3
MTCH
37
-3
VRTX
54
-2
URI
43
-2
NVDA
52
-2
MSI
50
-8
MET
58
2
NEM
48
-2
PEP
45
4
KR
63
6
RL
72
-3
MAC
65
-2
FLR
48
-4
KHC
20
3
EXR
51
-2
K
53
2
Financhill
Back

UroGen Pharma Stock Price Chart

The dark truth about AI

Click here to learn more...
Sell
43

URGN
UroGen Pharma

Last Price:
11.36
Seasonality Move:
5.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.

UroGen Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 12.05 Sell
20-day SMA: 11.99 Sell
50-day SMA: 12.21 Sell
200-day SMA: 14.16 Sell
8-day EMA: 11.93 Sell
20-day EMA: 12.08 Sell
50-day EMA: 12.39 Sell
200-day EMA: 13.6 Sell

UroGen Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 39.41 Sell
Chaikin Money Flow: 14788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.53 - 12.57) Sell
Bollinger Bands (100): (11.89 - 14.65) Sell

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for UroGen Pharma Stock

Is UroGen Pharma Stock a Buy?

  • UroGen Pharma share price is 11.47 while URGN 8-day simple moving average is 12.05, which is a Sell signal.
  • The stock price of URGN is 11.47 while UroGen Pharma 20-day SMA is 11.99, which makes it a Sell.
  • UroGen Pharma 50-day simple moving average is 12.21 while URGN share price is 11.47, making it a Sell technically.
  • URGN stock price is 11.47 and UroGen Pharma 200-day simple moving average is 14.16, creating a Sell signal.

URGN Technical Analysis vs Fundamental Analysis

Sell
43
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy or a Sell?

  • UroGen Pharma stock is rated a Sell
    The current UroGen Pharma [URGN] share price is $11.47. The Score for URGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.

UroGen Pharma Stock Info

Market Cap:
484.03M
Price in USD:
11.47
Share Volume:
325.33K

UroGen Pharma 52-Week Range

52-Week High:
20.70
52-Week Low:
10.60
Sell
43
UroGen Pharma (URGN) is a Sell

UroGen Pharma Share Price Forecast

  • What is the UroGen Pharma stock price today?
    The UroGen Pharma stock price is 11.47 USD today.
  • Will URGN stock go up or go down?
    UroGen Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is UroGen Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, UroGen Pharma is overvalued.

Is UroGen Pharma Stock a Buy?

  • UroGen Pharma share price is 11.47 while URGN 8-day exponential moving average is 11.93, which is a Sell signal.
  • The stock price of URGN is 11.47 while UroGen Pharma 20-day EMA is 12.08, which makes it a Sell.
  • UroGen Pharma 50-day exponential moving average is 12.39 while URGN share price is 11.47, making it a Sell technically.
  • URGN stock price is 11.47 and UroGen Pharma 200-day simple moving average is 13.60, creating a Sell signal.

Fundamental Analysis of UroGen Pharma

Is UroGen Pharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Technical Analysis of UroGen Pharma

Should I short UroGen Pharma stock?

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.